Clinical trial
Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West…
NCT00489658 · Epicentre, Other · Terminated
Key facts
| NCT number | NCT00489658 |
|---|---|
| Title | Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda |
| Official title | Efficacy and Safety of an Eflornithine + Nifurtimox Combination for Treatment of Late-Stage Human African Trypanosomiasis (HAT) in West Nile, Uganda |
| Acronym | NECS |
| Lead sponsor | Epicentre, Other |
| Collaborators | Médecins Sans Frontières, France |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Trypanosomiasis, African |
| Intervention type | Drug |
| Interventions | Eflornithine plus Nifurtimox combination therapy |
| Enrollment | 31 |
| Start date | Oct 1, 2002 |
| First posted | Jun 21, 2007 |
| Last update posted | Jun 21, 2007 |
| Countries | Uganda |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: